medRxiv preprint doi: https://doi.org/10.1101/2020.09.11.20192971; this version posted September 13, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Mask-Wearing During the COVID-19 Pandemic

Ashwin Aravindakshan1
Associate Professor
University of California, Davis

J√∂rn Boehnke
Assistant Professor
University of California, Davis

Ehsan Gholami
PhD Candidate
University of California, Davis

Ashutosh Nayak
Postdoctoral Scholar
University of California, Davis

1

Corresponding Author Email: aaravind@ucdavis.edu

1

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2020.09.11.20192971; this version posted September 13, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Mask-Wearing During the COVID-19 Pandemic
Abstract
Background
Masks have been widely recommended as a precaution against COVID-19 transmission. Several
studies have shown the efficacy of masks at curbing droplet dispersion in lab settings. Using
individual response data from the Imperial College London ‚Äî YouGov personal measures
survey, this study investigates reported mask use and its association with the spread of COVID19.
Methods
We examine the association of reported mask-wearing in a population within a country with the
growth rate of active cases COVID-19 cases. The analysis uses country-wide data from weekly
surveys of individuals‚Äô mask-wearing behavior in public places, as well as other concurrently
implemented non-pharmaceutical interventions, mobility changes, new cases of COVID-19 data
and other control variables. The mask-wearing data were obtained from the Imperial College ‚Äî
YouGov multi-country survey of people‚Äôs personal habits before and during COVID-19.
Because mask-wearing showed substantial variation across countries and over time, we use a
reduced form econometric model to relate population-wide changes in mask-wearing to the
growth rate in COVID-19.
Results
The results indicate that reported mask-wearing could play an important role in mitigating the
growth of COVID-19. Widespread mask-wearing within a country associates with an expected
7% (95% CI: 3.94% ‚Äî 9.99%) decline in the growth rate of daily active cases of COVID-19 in
the country. This daily decline equates to an expected 88.5% drop in the growth of daily active
cases over a 30-day period when compared to zero percent mask-wearing, all else held equal.
The decline in daily growth rate due to the combined effect of reported mask-wearing, reduced
social mobility, and non-pharmaceutical interventions averages 28.1% (95% CI: 24.2%-32%).
These estimates remain robust across multiple sensitivity analyses.
Conclusions
Face mask usage as a preventative measure against the transmission of COVID-19 varies widely
across countries. This observational study uses data from 24 countries and finds that reported
face mask usage associates with a decline in new COVID-19 cases. Even though the model
controls for a large variety of variables that affect spread, and we run a number of robustness
checks, it remains possible that some of the decline associated with face masks is related to
confounding variables not included in the model. In summary, due to the confounding variables
and the variations in the type of mask and its usage, randomized control trials of mask usage in
populations are needed to determine the true effect of mask‚Äìwearing on mitigating the
transmission of infectious respiratory diseases.

2

medRxiv preprint doi: https://doi.org/10.1101/2020.09.11.20192971; this version posted September 13, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

1. Introduction
In response to the COVID-19 pandemic, multiple countries curbed the spread of the disease by
enforcing strict policy measures such as lockdowns and shelter-in-place orders [1]. The nonpharmaceutical interventions (NPIs) included closures of school, restaurants, bars, retail outlets
and other non-essential businesses, as well as shelter-in-place policies and the prohibition of large
gatherings (e.g., limited to 10 people) [2]. These institutional measures aimed to reduce the
exposure of susceptible individuals to symptomatic and asymptomatic infected individuals by
decreasing social mobility (e.g., going out to movies, concerts and restaurants, assembling in large
groups) and encouraging social distancing. (e.g., 1m-2m physical distancing) [3,4].
Unlike the widespread and proactive implementation of lockdowns and physical distancing
measures, the usage of masks varied widely across countries. Some countries quickly adopted
guidelines for mask usage (e.g., Malaysia, Singapore, Taiwan, and Thailand) while others did not
recommend using face mask unless sick [5,6,7]. Indeed, the World Health Organization updated
its mask-wearing guidelines only on June 5, 2020 [8], to recommend that ‚ÄúThe general public
should wear non-medical masks where there is widespread transmission and when physical
distancing is difficult, such as on public transport, in shops or in other confined or crowded
environments.". Due to these changing guidelines and uneven implementations, mask-wearing
varied dramatically across countries and over time [9].
Multiple studies have investigated the impact of various governmental NPIs [3,10,11,12], that
encourage physical distancing and the wearing of face masks [13,14,15]. In each case they find
that NPIs, physical distancing, and face mask usage reduce the transmission of COVID-19.
However, the interventions, government policies, and individual measures seldom act in isolation.
Treating these measures in isolation could lead to under- or over-estimation of their effectiveness
at reducing the spread of the disease, biasing the assessments of the measure‚Äôs impact. In this
study, we investigate the association of population-wide mask-wearing with the number of
COVID-19 cases, concurrent with other individual and institutional measures. Specifically, we
expand on the current stream of research by simultaneously considering the effects of NPIs and
social mobility along with a population‚Äôs reported usage of face masks in public places in a
reduced-form econometric model (see examples in [3] and [10]). Using data from 24 countries, we
identify the effect of each measure by exploiting the country-wise differences in the (1) percentage
of the population who report wearing a face masks in public places (YouGov Survey Data [9]), (2)
social mobility across multiple categories such as Parks and Transit Locations (using Google
Mobility Reports [16]) and NPI implementations (using CoronaNet-Project [1])

2. Methods
This study is a cross-sectional analysis of the effects of personal and governmental measures
across 24 countries on mitigating COVID-19 disease spread. The data used in this study were
collected from February 21, 2020 to July 8, 2020, representing 139 days of data for each country.
All analysis presented in this paper uses publicly available data. Subsequently, we first present
the data and then the model-based analysis.

3

medRxiv preprint doi: https://doi.org/10.1101/2020.09.11.20192971; this version posted September 13, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Key Variables of Interest
Mask-Wearing: Survey data released by the Institute of Global Health Innovation (IGHI) at
Imperial College London and YouGov [9] provide reported mask-wearing across multiple
countries. The survey covers 26 countries (as of July 8, 2020), with around 21,000 people
interviewed each week. We restrict our analysis to 24 countries, because two countries ‚Äì China
and Hong Kong ‚Äì do not have publicly available data on the social mobility dimensions we
control for in this study. The data present global insights on people‚Äôs reported behavior in
response to COVID-19. The dataset provides the percentage of population in each country who
report to wear a mask in public places. Because these surveys were conducted at an interval of
several days, we interpolate (linearly) to estimate the percentage of the population that would
wear masks in public spaces for days when the data were unavailable (Figure 1). We use the
significant variation of mask-wearing across countries to measure the association of people
reporting mask wearing and the spread of COVID-19.

Figure 1. Percentage of people who say they are wearing a face mask in public spaces

Social Mobility: Google Community Mobility Reports provide data on relative mobility changes
with respect to an internal baseline across multiple categories namely, retail and recreation,
groceries and pharmacies, parks, transit stations, workplaces, and residential (Figure 2). A
summary for the community mobility is shown in Table S2 in the Supplement. Apart from the
Google Mobility reports, we also utilize mobility data from Apple to test the robustness of the
model to different measures of mobility. We note that neither Google nor Apple provide absolute
measures of mobility, but rather present relative changes with respect to benchmarks they use
internally. Finally, drops in mobility could be driven by both individual actions (e.g., cautious
behavior) as well as institutional actions due to NPIs enacted by governments. To control for
mobility declines due to institutional actions, we also include country-specific interventions
enacted both nationally and provincially.

4

medRxiv preprint doi: https://doi.org/10.1101/2020.09.11.20192971; this version posted September 13, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure 2 (a) Social Mobility for Italy from Google
Community Mobility Reports

Figure 2 (b) Social Mobility for Italy from Apple
Community Mobility Reports

Figure 2. Social mobility from Google Mobility Reports and Apple Mobility Reports for Italy. Social mobility for
all the 24 countries is shown in Figure S8 in Supplementary.

Non-Pharmaceutical Interventions: Governments across the 24 countries enforced different
policies to control the spread of COVID-19. Prior research has shown that these policies played a
significant role in reducing human to human physical contacts and led to a slowdown in the
spread of the disease. However, these policies were implemented in different ways, some
nationally, some provincially. We use data from COVID-19 Government Response Event
Dataset [1] to control for government policies in estimating the effect of masks. Figure S10 lists
the types and counts of national and provincial government policies implemented across the 24
countries we consider in this study. The dataset contains 5,816 entries on policies at National and
Provincial level. Finally, inclusion of these interventions helps control for some of the observed
drops in mobility that are not necessarily associated with individual actions but by the presence
of institutional policies. Detailed information about the interventions are included in the
Supplement (Section S2.5).
Covariates
Because the data span multiple countries and weeks, we include time and country fixed effects in
the model. The model controls for country-level heterogeneity using fixed-effects, where the
variable for a country assumes a value of one if the data considered are specific to that country,
and zero otherwise. This allows for control of country-level characteristics that are not in the
model and helps reduce the errors due to omitted variables in our analysis. In addition to
country-level differences, we also control for time-based differences (e.g., people are more aware
and cautious over time) by incorporating time-fixed effects, where the variable Weekt takes a
value of 1 if the data are from week ‚Äòt‚Äô (where t =1 in the first week for a given country in the
data). In addition, we control for each country‚Äôs testing capability (Figure 3a) by accounting for
the total number of daily tests in the country. Finally, we also control for actions people take to
educate themselves by including the Google Trends (Figure 3b) data for the search term
‚Äòcoronavirus‚Äô.

5

medRxiv preprint doi: https://doi.org/10.1101/2020.09.11.20192971; this version posted September 13, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure 3 (a) Number of COVID-19 Tests per Thousand
People in Italy

Figure 3 (b) Google Trends for Search Term
coronavirus in Italy.

Figure 3. Number of COVID-19 Tests and Google Trends (per thousand people) for Italy. Data for all the 24
countries is shown in Figure S13 and Figure S14 respectively in Supplementary.

Outcome Variable
Data for the number of active daily cases in each country were obtained from the Johns Hopkins
University School of Public Health [17]. We use a seven-day moving average of cumulative
confirmed cases and cumulative recovered cases to compute daily active cases and daily growth
rate. The dataset aggregates this information across multiple national, state, and local health
departments within each country. The daily growth rate is then related, by means of a reducedform econometric model, to the independent variables described earlier. We describe the
derivation in the Supplement (Section S1.1). We illustrate the daily cases and growth rate for one
country, Italy, in Figure 4.

Figure 4 (a) CoVID-19 Cases in Italy.

Figure 4 (b) Growth rate in Italy.

Figure 4. Daily Active cases and growth rate in Active cases for Italy. Vertical green line in (b) shows the start of
data collection for Italy. Vertical red line in (b) shows the end of 60 days of data collection for Italy. Data for all the
24 countries is shown in Figure S6 and Figure S7 respectively in the Supplement.

Analysis
A reduced form econometrics model was used to relate the growth rate of daily active infections
to the independent variables described earlier. Similar models have been used by [3] to
determine the effect of anti-contagion policies on the spread of COVID-19. In brief, the model
assumes that the daily growth rate (ratio of active infections today to active infections the day
before) is affected by the institutional measures such as NPIs as well as individual measures such
as social mobility and mask-wearing. The covariates listed above help control for other factors

6

medRxiv preprint doi: https://doi.org/10.1101/2020.09.11.20192971; this version posted September 13, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

that could affect growth over time. Because the epidemiological parameters for new diseases
such as COVID-19 might not be well understood, reduced form techniques allow for the
estimation of the impact of governmental and personal measures to help contain the spread of the
virus. The model we use initializes when a country reaches 20% of peak new cases as observed
by July 8, 2020 to filter out the high variation in growth rates when the number of cases is very
low at the beginning of the pandemic. For robustness, we also test other starting times in the
Supplement and find results in line with the ones presented here. The Supplement also provides
further details about the methodological approach as well as information on the model
formulation used.
We provide some brief notes on the operationalization of the independent variables and the
model initialization below:
1. Responses to the survey about mask-wearing are subject to biases. For example,
individuals might overestimate the efficacy of their mask or their wearing pattern. To
alleviate some of these concerns, we compute the natural log of the mask-wearing
variable to discount its impact on the growth of cases. This transformation yields a curve
that grows at a slower rate as the values of mask-wearing increase, thereby diminishing
the impact of higher levels of mask-wearing. We also test for other functional forms
(square-root and linear) and present those results in the Supplement (Table S7).
2. Due to the high correlation across the different mobility data categories obtained from
Google, we only include Mobility: Parks and Mobility: Transit Stations in the model.
Because we are interested in determining the impact of mobility in general, the two
mobility variables suffice in capturing the individual‚Äôs movement patterns during this
time. In Supplement S3.4, we present results including other types of mobility, and also
run the model with Apple Mobility data in the place of Google Mobility Reports.
3. The CoronaNet dataset from [1] collected information on all the government policies
introduced by different countries across the world. They categorized the policies into 19
different policy-types. We use their categorization in the model. From February 21, 2020
to July 8, 2020, we check if a policy p was implemented in a country j on day t. If the
policy was implemented, we assign a value of 1 to ùë†ùëó,ùë°,ùëù , where sÔøº represents the level of
policy coverage. If the policy was introduced at a provincial level, ÔøºweÔøºùë†ùëó,ùë°,ùëù Ôøº by the
population of the state. Because several policies were introduced at the same time or
close together, they too suffered from collinearity issues. To minimize multicollinearity
issues, we choose only a specific set of policies to include in the analysis. The
Supplement (Section S2.5) discusses this selection mechanism.
4. Due to uncertainty of the lag in COVID-19 incidences and the difficulties in detection
during the early days of the disease (Woloshin et al 2020), similar to prior research we
tested the focal model across multiple lag periods (shift) from zero to 14 days and for
different initialization thresholds (th) for each country (zero percent to 20% of a
country‚Äôs peak daily cases). We chose the best shift and th values using a k-fold crossvalidation process (k=5). The chosen model had the highest maximum likelihood
estimate of the data as well as the lowest prediction error. We discuss this procedure in
the Supplement (Section S4.1). The results presented in the next section correspond to a
model with a shift of nine days and a th of 20% of peak new cases by July 12, 2020.
Finally, the model was estimated on 1,422 observations across 24 countries, averaging 60
observations per country. We restrict our analysis to the first 60 days. However, we test

7

medRxiv preprint doi: https://doi.org/10.1101/2020.09.11.20192971; this version posted September 13, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

the robustness of the findings for other lengths of data. This allows for greater variation
in mask usage within the data.
In the next section, we describe our results and their policy implications.
3. Results
The results indicate that individual (mask-wearing, social mobility) and institutional measures
(NPIs) could play a role in mitigating the growth of COVID-19. The estimates from the focal
reduced form model for these measures and their corresponding confidence intervals are shown
in Figure 5. The full table of results, along with results for all robustness checks are provided in
Supplement (Section 3). We first list the results of the key measures we consider and then
discuss their implications.

Figure 5. Parameter estimates for the Growth rate model. The blue dot indicates the point estimates and the
horizontal lines indicate 95% confidence interval around the estimate (Masks transformed as ln(1+mask)). Results
for different transformations of Mask and other covariates is shown in Figure S16.

Masks. The model finds that a reported mask wearing of 100% is associated with an average 7%
(95% CI: 3.94% ‚Äî 9.99%) drop in daily COVID-19 cases. While this daily effect appears small
over a 30 day period, 100% reported mask-wearing leads to approximately 88.5% (95% CI:

8

medRxiv preprint doi: https://doi.org/10.1101/2020.09.11.20192971; this version posted September 13, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

68.7% ‚Äî 89.2% ) decline in active cases when compared to the situation where 0% of the people
report wearing masks (all else remaining the same across the two scenarios). Modifying the
functional form of the mask variable did not appreciably change the association. For example, in
the linear model, masks are associated with an average 8.69% (95% CI: 5.63% ‚Äî 11.66%) drop
in daily growth rate and for the square root model the expected daily drop in growth rate was
7.89% (95% CI: 4.81% ‚Äî 10.87%). The stability of the results seems to indicate that maskwearing can potentially play a significant role in mitigating the spread of the disease. Figure 6
plots the ratio of active cases under different proportions of respondents who claim to wear
masks as against no mask wearing.

Figure 6. Ratio of Active cases under different percentage of mask wearing in public spaces as compared to 0 mask
wearing over different periods (in days) . The shaded bars represents in ratio while the black vertical lines represent
the 25th and 75th percentile of the ratio (from simulations using Krinsky-Robb method)

Mobility and NPIs. As expected, the model finds that a rise in mobility links with a rise in the
number of cases. Specifically, the selected mobility variables associate with a combined 8.1%
(95% CI: 5.6% - 10.6%) drop in daily case numbers. Similarly, we find that the implementation
of NPIs also associate with a drop in daily growth rates across countries. After accounting for
mobility declines, the NPI measures ‚ÄòQuarantine, ‚ÄòExternal Border Restrictions,‚Äô and ‚ÄòClosure
and Regulation of Schools‚Äô link with the highest declines in the growth of cases. Overall, all
NPIs included in the model led to a decrease in the growth rate of COVID-19. This finding
confirms multiple studies that investigated the effects of NPIs at limiting the spread of COVID19 [10,18]. Overall, we find that if the NPIs were enacted uniformly across the whole country,
then the combined association of the NPIs with the decline of growth in daily cases of COVID19 would average 13% (95% CI: 9.2% - 16.2%). We determine the combined effect using the
Krinsky-Robb method, a Monte Carlo simulation used to draw samples from a multivariate
normal distribution. Supplement S3.1 provides more details on this method.
Control Functions and Robustness Checks
Due to nearly concurrent enactments and blanket coverage of policies and precautionary
behaviors within countries, the individual (e.g., masks, limiting mobility) and institutional (NPIs)

9

medRxiv preprint doi: https://doi.org/10.1101/2020.09.11.20192971; this version posted September 13, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

measures correlate in time. This precludes causal identification of each measure‚Äôs individual
effect on disease mitigation. In other words, because mask-wearing, mobility reductions, and
NPIs occur at similar times, their effects are intertwined and difficult to determine separately.
For some variables such as mobility and NPIs, we lack the necessary data to fully control for
some of these issues. In the case of mask-wearing, even though we cannot eliminate the
simultaneity, we attempt to reduce the effects of confounding variables by employing control
functions [19]. In addition, [20] note that control functions make the intervention exogenous in a
regression equation. To create a control function, we use country mortality data for SARS,
H1N1, and MERS to predict the propensity of mask-wearing in each country (see Supplement
S4.5.2 for more details). Next, we compute the control function by determining the predicted
mask-wearing residuals (Predicted Mask-Wearing minus Actual Stated Mask-Wearing),
allowing for better identification of the effect of reported mask-wearing on COVID-19 case
numbers.
Using this procedure, we find that if 100% of the population claimed to wear masks, then maskwearing relates with an average 4.95% (95% CI: 2.26% ‚Äî 7.53%) drop in daily growth rate
(nine days later), when compared to zero percent reported mask-wearing. While we are careful to
note that this estimate could still be affected by confounding variables, this result lends further
support to the estimate presented earlier. In summary, widespread mask-wearing could lead to a
significant decline in the growth of COVID-19.
To help determine the accuracy of the results we run several robustness checks (see Supplement
S4):
(1) We vary the lag period (shift) from 0 to 14 days. The results show that the estimates of
the individual and institutional measures are relatively stable.
(2) We also vary the length of time we consider in the analysis. The model considered 60
days of data for each country. We vary this to estimate the model on 35, 45, 55, 65, 75
and 85 days of data. We find that the results remain consistent to these changes.
(3) We replace Google mobility data with Apple mobility data. The model estimates remain
robust to this change.
(4) We vary the functional form of how mask-wearing relates to the growth of COVID-19.
The results do not vary appreciably with respect to this to this change.
(5) We also test the robustness of the analysis by modifying the data using exponential
smoothing. Specifically, for any day t, the focal model in Equation (1) ignores the value
of the independent variables from days t-shift+1 to t (discussed in Figure S1). In the
model we use for the robustness check, we do not ignore values between t-shift and t and
use exponential smoothing to average the intervening data. Finally, we also modify the
interpolation method from linear (current) to quadratic. We find that the results are stable
to all these modifications.
The Supplement details all the robustness checks and simulations as well as their results.

10

medRxiv preprint doi: https://doi.org/10.1101/2020.09.11.20192971; this version posted September 13, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

4. Discussion
Over the past few months, several studies have investigated the efficacy of masks at minimizing
droplet dispersion [21,22] and the potential consequences of their use [14,23] in the general
population. Although no randomized control trial on the efficacy of face mask usage in the
general population exists, [15,14] provide compelling evidence for the use of face masks through
a systematic review of the multiple observational studies and the evidence thus far. Both studies
project that the use of face masks reduces the transmission of disease. While the type of face
mask as well as the timing and length of use can affect its efficacy, its use as a precautionary
principle has been strongly advised [24]. Despite this preponderance of evidence, face mask use,
in the US remains controversial [25,26]. Additionally, as observed in the data, even in countries
where masks do not face similar headwinds and as support for mask usage gathers further
evidence, face mask use is not as common place (e.g., Denmark, Norway, Sweden, Finland,
Australia), even as a precautionary principle.
This study links the growth in active cases of COVID-19 in a country, to a population‚Äôs reported
wearing of face masks in public places over time. The model also includes other measures that
could simultaneously impact the growth of the disease as face mask usage changes over time.
After accounting for these measures and controlling for other covariates, the results indicate that
reported face mask use is associated with a decline in the growth of COVID-19. More precisely,
if 100% of the population claimed to wear masks, then mask-wearing is associated with an
average 7% decline in the growth of COVID-19. This association persists across multiple
robustness checks and model formulations. A decline of 7% corresponds to an 88.5% drop in the
number of active cases 30 days later. Taken together with the other measures (mobility changes,
NPIs), the combined association obtained via the Krinsky-Robb method of individual and
institutional measures on the decline in the daily growth of COVID-19 is 28.1% (95% CI:
24.2%-32%).

Limitations
This study has several limitations. First, countries enacted multiple NPIs simultaneously. This
precludes us from identifying the effectiveness of NPIs separately. Second, the mobility data
provided by Google and Apple are only indicative of the relative changes from a benchmark, so
their association with disease spread should be interpreted with precaution.
Third, even though we consider multiple NPIs and mobility measures and control for populationwide awareness, testing, and country and time differences, there could be several variables that
we do not or cannot include due to the lack of data. For example, one of the NPIs we consider
relates to health announcements (e.g., handwashing, coughing into one's elbow, etc.). However,
the model only notes the NPI and not the adoption of these practices in the general population.
While some data (e.g. sale of soap, cleansers, etc.) could approximate this, multiple confounding
variables still exist and thus limit the extent to which we can apply any causal interpretation of
the results. We attempt to provide better insights using a control function approach, however,
stop short of making causal claims.

11

medRxiv preprint doi: https://doi.org/10.1101/2020.09.11.20192971; this version posted September 13, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Fourth, our analysis was conducted at the country level due to data restrictions. However, mask
usage, mobility changes as well as the implementation of NPIs most likely vary within the
country. Nevertheless, the analyses in this study are helpful at understanding the practical
implementation of mask usage policy within a country.
Finally, we rely on the accuracy of data collected by third parties. Inconsistencies in testing,
reporting, and recording of the data could lead to errors in the results obtained. Additionally,
mask-types and mask-wearing patterns could vary across countries, individuals, and over time.
This limitation affects all observational COVID-19 population-based studies. Randomized
control trials of mask usage in populations are needed to determine the true effect of mask‚Äì
wearing on mitigating the transmission of infectious respiratory diseases.

5. Conclusions
The population-wide usage of face masks as a preventative measure against the transmission of
COVID-19 varies widely across countries. Using data from 24 countries, this study finds that
reported face mask usage associates with a decline in the growth rate of COVID-19. Even though
we control for multiple variables that could affect spread and include multiple robustness checks,
it remains possible that some of the decline associated with face masks may be related with other
confounding variables not included in our model.

12

medRxiv preprint doi: https://doi.org/10.1101/2020.09.11.20192971; this version posted September 13, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

6. References
1. C. Cheng, J. Barcelo, A.S. Harnett, R. Kubinec and L. Messerschmidt, COVID-19
Government Response Event Dataset (CoronaNet v.1.0). Nat. Hum. Beh. 4, 756-768 (2020).
2. A. Pan, L. Liu, C. Wang, H.Guo, X. Hao, Q. Wang, J. Huang, N. He, H. Yu, X. Lin, S. Wei
and T. Wu, Association of Public Health Interventions with the Epidemiology of the
COVID-19 Outbreak in Wuhan, China. JAMA. 323 (19) 1915-1923 (2020).
3. S. Hsiang, D. Allen, S. Annan-Phan, K. Bell, I. Bolliger, T. Chong, H. Druckenmiller, L. Y.
Huang, A. Hultgren, E. Krasovich, O. Lau, J. Lee, E. Rolf, J. Tseng and T. Wu. The Effect of
Large-Scale Anti-Contagion Policies on the COVID-19 Pandemic. Nature 584, 262-267
(2020).
4. S. G. Benzell, A. Collis and C. Nicolaides. Rationing social contact during the COVID-19
pandemic: Transmission risk and social benefits of US locations. PNAS 117 (26) 1464214644 (2020)
5. https://www.cdc.gov/media/releases/2020/t0212-cdc-telebriefing-transcript.html (last
accessed on September 9, 2020)
6. https://twitter.com/Surgeon_General/status/1233725785283932160?s=20 (last accessed on
September 9, 2020)
7. S. Feng, C. Shen, N. Xia, W. Song, M. Fan and B. J. Cowling. Rational Use of Face Masks
in the COVID-19 Pandemic. The Lancet: Resp. Med. 8 (5) 434-436 (2020).
8. https://apps.who.int/iris/handle/10665/332293 (last accessed on September 9, 2020)
9. https://yougov.co.uk/topics/international/articles-reports/2020/03/17/personal-measurestaken-avoid-covid-19 (last accessed on September 9, 2020)
10. S. Flaxman, S. Mishra, A. Gandy, H.J.T. Unwin, T.A. Mellan, H. Coupland, C. Whittaker, H.
Zhu, T. Berah, J.W. Eaton, M. Monod, Imperial College COVID-19 Response Team, A.C.
Ghani, C.A. Donnelly, S.M. Riley, M.A.C. Vollmer, N.M. Ferguson, L.C. Okell and S.
Bhatt. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.
Nature 584 257-261 (2020).
11. Auger K, Shah S, Richardson T, D. Hartley, M. Hall, A. Warniment, K. Timmons, D. Bosse,
S.A. Ferris, P.W. Brady. A.C. Schondelmeyer and J.E. Thompson. Association between
statewide school closure and COVID-19 incidence and mortality in the US. JAMA. 324 (9)
859-870 (2020).
12. C. Courtemache, J. Garuccio, A. Le, J. Pinkston, A. Yelowitz. Strong Social Distancing
Measures In The United States Reduced The COVID-19 Growth Rate. Health Affairs. 39 (7)
1237-1246 (2020)
13. W. Lyu and G. L. Wehby. Community Use Of Face Masks And COVID-19: Evidence From
A Natural Experiment Of State Mandates In The US. Health Affairs 39 (8) 1-7 (2020).
14. D. K. Chu, E. A. Akl, S. Duda, K. Solo, S. Yaacoub, H.J. Schunemann, Physical distancing,
face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and
COVID-19: a systematic review and meta-analysis. The Lancet 395 1973-87 (2020)
15. J. Howard, A. Huang, A. Li, Z. Tufekci, Z. Vladimir, HM van der Westhuizen, A von Delft,
A. Price, L. Fridman, L. H. Tang, V. Tang, G. L. Watson, C.E. Bax, R. Shaikh, F. Questier,
D. Hernandez, L. F. Chu, C.M. Ramirez and A. W. Rimoin. Face Masks Against COVID-19:
An Evidence Review https://www.preprints.org/manuscript/202004.0203/v1 (last accessed
on September 9 2020).
16. https://www.google.com/covid19/mobility/ (last accessed on September 9 2020)

13

medRxiv preprint doi: https://doi.org/10.1101/2020.09.11.20192971; this version posted September 13, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

17. E. Dong, H. Du and L. Gardner An interactive web-based dashboard to track COVID-19 in
real time. The Lancet: Inf. Dis. 20 (5) 533-534 (2020).
18. N. G. Davies, A. J. Kucharski, R. M. Eggo, A. Gimma, W. J. Edmunds. Effects of nonpharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services
in the UK: A modelling study. The Lancet: Pub. Health 5 (7) 375-385 (2020).
19. J. M. Wooldridge. Control function methods in applied econometrics. Journal of Human
Resources 20 420-445 (2015).
20. J. Heckman and R. Richard. Alternative Methods for Evaluating the Impact of Interventions:
An Overview. Journal of Econometrics 30 (1-2):239-267 (1985).
21. P. Bahl, S. Bhattacharjee, C. de Silva, A. A. Chughtai, C. Doolan and C. R. MacIntyre. Face
cCoverings and Mask to Mini9mise Droplet Dispersion and Aerosolisation: A Video Case
Study. Thorax. 1-2 (2020): doi:10.1136/thoraxjnl-2020-215748
22. M. Riedeker and D. H. Tsai. Estimation of Viral Aerosol Emissions from Simulated
Individuals With Asymptomatic to Moderate Coronavirus Disease 2019. JAMA Net. Op. 3
(7):e2013807 (2020)
23. C. J. Worby and H.H Chang. Face mask use in the general population and optimal resource
allocation during the COVID-19 pandemic. Nat. Comm. 11 40-49 (2020)
24. T. Greenhalgh, M. B. Schmid, T. Czypionka, D. Bassler and L. Gruer. Face masks for the
public during the covid-19 crisis. BMJ 2020;369:m1435
25. https://www.sciencenews.org/article/covid-19-coronavirus-why-wearing-masks-controversial
(last accessed on September 9 2020)
26. https://www.wsj.com/articles/masks-could-help-stop-coronavirus-so-why-are-they-stillcontroversial-11593336601 (last accessed on September 9 2020)

14

